Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM), PRC-based maker and marketer of pharmaceutical and health supplement offerings in China for a multitude of diseases and conditions, reported today that it signed a Letter of Intent with the Fourth Military Medical University to together carry out Phases I to III clinical trials for the Viacom Pine II Cream drug. The letter has been turned in to China’s military authorities for consent. Biostar shares are trading 17.69% higher today.
Lattice Semiconductor (NASDAQ:LSCC): Revenue for Lattice, compared to earlier guidance from April 19, 2012, was planned to be nearly flat to up to 4% on a sequential basis. Gross margin percentage is predicted to be around 51%, plus or minus 1%. This is in comparison to earlier guidance to be around 55% plus or minus 1%. Total operating costs are predicted to be about $39.5M, with around $1M in acquisition-related costs. Shares of Lattice are trading 12.69% lower today.
Credit Suisse Group AG (NYSE:CS) has been encouraged by the Swiss National Bank to better its capital by stopping dividends or issuing shares to generate cash to protect it from the risk of a heightening in the euro zone banking crisis. The central bank points out that leverage stays “very high” at both CS and UBS, and both ought to trim their balance sheets.
Piedmont Natural Gas Company, Inc. (NYSE:PNY) has presented a $75,000 grant to finance a collaboration with Furman, Duke and Vanderbilt universities that will promote student-led work on environmental stewardship and energy sustainability projects. Shares of Piedmont are trading 0.34% higher today.
Alexandria Real Estate Equities, Inc. (NYSE:ARE): In its second quarter of 2012, Alexandria has raised its quarterly cash dividend to 51 cents per share from 49 cents. This increase will be paid on July 16 to shareholders of record as of June 29, 2012. Shares of the company are trading 2.01% higher today.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.